aTyr Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell aTyr Pharma and other ETFs, options, and stocks.About ATYR
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1.
CEOSanjay S. Shukla
CEOSanjay S. Shukla
Employees59
Employees59
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2005
Founded2005
Employees59
Employees59
ATYR Key Statistics
Market cap75.87M
Market cap75.87M
Price-Earnings ratio-0.92
Price-Earnings ratio-0.92
Dividend yield—
Dividend yield—
Average volume2.00M
Average volume2.00M
High today$0.795
High today$0.795
Low today$0.7579
Low today$0.7579
Open price$0.7579
Open price$0.7579
Volume1.56M
Volume1.56M
52 Week high$7.29
52 Week high$7.29
52 Week low$0.64
52 Week low$0.64
Stock Snapshot
As of today, aTyr Pharma(ATYR) shares are valued at $0.76. The company's market cap stands at 75.87M, with a P/E ratio of -0.92.
As of 2025-12-12, aTyr Pharma(ATYR) stock has fluctuated between $0.76 and $0.80. The current price stands at $0.76, placing the stock +0.4% above today's low and -4.3% off the high.
aTyr Pharma(ATYR) shares are trading with a volume of 1.56M, against a daily average of 2M.
During the past year, aTyr Pharma(ATYR) stock moved between $0.64 at its lowest and $7.29 at its peak.
During the past year, aTyr Pharma(ATYR) stock moved between $0.64 at its lowest and $7.29 at its peak.
Analyst ratings
70%
of 10 ratingsBuy
30%
Hold
70%
Sell
0%
People also own
Based on the portfolios of people who own ATYR. This list is generated using Robinhood data, and it’s not a recommendation.